An individualized neoantigen mRNA vaccine was tested in patients with early-stage triple-negative breast cancer and showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results